Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors
Clinical trial NCT02472977 · TERMINATED
Trial details
- NCT number
- NCT02472977
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-13
- Primary completion
- 2017-01-27
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.